Pre-Biopsy Biomarker Tests for Prostate Cancer Risk Assessment - Urology Times


4/25/2022 12:00:00 AM3 yearsago
by Judd W. Moul, MD

Judd W. Moul, MD, FACS, introduces available blood- and urine-based biomarker tests for prostate cancer screening, and discusses how they might overcome limitations of commonly used modalities.

Patient Case: A 64-Year-Old Man with Elevated PSA Levels

  • A 64-year-old-man underwent PSA testing during his annual physical with his primary care physician; PSA was 5.6 ng/mL and PSA density… [+3765 chars]

    full article...